Pernod Ricard

COVID-19 outbreak's impact

14/02/20 -"Despite the FY20 warning due to the coronavirus which should have a major impact on Chinese consumption in the next half, we believe that Pernod Ricard’s long-term growth remains intact."

PDF page sample
Pages
52
Language
English
Published on
14/02/20
Download
You may also be interested by these reports :
02/09/25
Autumn approaches (again) and Nestlé changes the CEO once more
01/09/25
We have updated our DCF valuation to reflect slightly stronger than expected FY24/25 EBITDA of USD 7,422m (+15% vs. forecast), resulting in modest ...
28/08/25
Pernod Ricard reported stronger-than-expected profits despite an organic decline in recurring operations. Challenges are anticipated in H1 26, ...
26/08/25
We have updated our model to reflect the Q2 FY25 sales of EUR 1.7bn, representing a 9.5% LFL decline, alongside the company’s downwardly-revised ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO